Beta-Blockers in High-Risk Outpatients with Chronic Obstructive Pulmonary Disease are Associated with All-Cause Mortality – The STATUETTE Cohort Study

BACKGROUND: Beta-blockers have been proposed to improve COPD-related outcomes, yet studies report conflicting results. We aimed to investigate the effect of beta blockers on time-to-first exacerbation and all-cause mortality in high-risk COPD outpatients. METHODS: All COPD outpatients managed at the...

Descripción completa

Detalles Bibliográficos
Autores principales: Damkjær, Mathias, Suppli Ulrik, Charlotte, Godtfredsen, Nina, Håkansson, Kjell E J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402979/
https://www.ncbi.nlm.nih.gov/pubmed/34465987
http://dx.doi.org/10.2147/COPD.S315151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402979/
https://www.ncbi.nlm.nih.gov/pubmed/34465987
http://dx.doi.org/10.2147/COPD.S315151

Ejemplares similares